Connect with us

Hi, what are you looking for?

Digital Health

Impedimed Device Gets Breakthrough Designation for Kidney Failure

The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis. 

Impedimed Device Gets Breakthrough Designation for Kidney Failure

The Food and Drug Administration granted breakthrough device designation to Impedimed’s Sozo device for kidney failure. The company’s bioimpedance spectroscopy device uses a mild electrical current to measure users’ body composition, and in this case, it would be used to come up with a more precise measurement for how much fluid should be removed during dialysis.

The current standard of care is simply to measure changes in weight between appointments. But this is a crude tool, and can miss other causes for weight fluctuations. For example, some patients with chronic kidney disease develop protein energy wasting, where they’re losing muscle mass but retaining fluid. Removing too much fluid or too little fluid can be bad for patients.

Impedimed’s SOZO Device. Photo credit: Impedimed

“They’re looking for a fast, highly accurate, reliable way of knowing how much fluid to remove off that patient every session,” Impedimed CEO Rick Carreon said in an interview.“…Your ability to remove fluid at a lower rate in a more precise manner can extend lives and improve outcomes, and benefit patients over time,” he said.

The FDA’s Breakthrough Device Designation is reserved for devices that could provide more effective treatment for life-threatening or debilitation conditions. It would allow Impedimed to work closely with the agency for a speedier review.

The company had been planning to seek breakthrough designation for some time, Carreon said. Its device has already gotten a CE mark in Europe for managing patients with renal failure.

Impedimed has four other clearances with the FDA, including using its device to detect lymphedema in cancer patients. 

“If you can see one clinic that’s more successful, and learn from them, that’s where we see population health and dialysis really start to compound,” he said.

Seen on MedCity News: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News


PocDoc, the digital health platform and personal diagnostics provider, has launched what it says is a world-first smartphone-based test for cardiovascular disease.


Focused on connecting startups in the Medtech industry with potential investors, this can't miss event features the globe's most promising companies


The technology could greatly aid spinal surgeons in planning surgical interventions in advance.   


Emerging HealthTech company, Stasis Labs, Inc. intends to bridge the gap between clinicians and their patients with an all-in-one FDA-cleared hardware and software solution,...

You May Also Like


Today & Tomorrow: Digital Solutions in HealthTech Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare...


In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...


Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...


The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.